These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34592639)

  • 1. Low-dose ketamine infusion for treating subjective cognitive, somatic, and affective depression symptoms of treatment-resistant depression.
    Chen MH; Wu HJ; Li CT; Lin WC; Tsai SJ; Hong CJ; Tu PC; Bai YM; Mao WC; Su TP
    Asian J Psychiatr; 2021 Dec; 66():102869. PubMed ID: 34592639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD).
    Chen MH; Lin WC; Wu HJ; Cheng CM; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Su TP
    J Affect Disord; 2019 May; 251():162-169. PubMed ID: 30925267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of treatment refractoriness and brain-derived neurotrophic factor Val66Met polymorphism on antidepressant response to low-dose ketamine infusion.
    Chen MH; Lin WC; Tsai SJ; Li CT; Cheng CM; Wu HJ; Bai YM; Hong CJ; Tu PC; Su TP
    Eur Arch Psychiatry Clin Neurosci; 2021 Oct; 271(7):1267-1274. PubMed ID: 33959800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression.
    Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
    CNS Spectr; 2021 Aug; 26(4):362-367. PubMed ID: 32419678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion.
    Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
    J Affect Disord; 2018 Dec; 241():1-7. PubMed ID: 30081380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.
    Chen MH; Wu HJ; Li CT; Lin WC; Tsai SJ; Hong CJ; Tu PC; Bai YM; Mao WC; Su TP
    Hum Psychopharmacol; 2022 Mar; 37(2):e2820. PubMed ID: 34597436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Neurofilament Light Chain With the Antidepressant Effects of Low-Dose Ketamine Infusion Among Patients With Treatment-Resistant Depression.
    Lin WC; Su TP; Li CT; Wu HJ; Bai YM; Liu YL; Tu PC; Chen MH
    Int J Neuropsychopharmacol; 2023 Sep; 26(9):649-653. PubMed ID: 37490687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study.
    Chen MH; Kao CF; Tsai SJ; Li CT; Lin WC; Hong CJ; Bai YM; Tu PC; Su TP
    Genomics; 2021 Mar; 113(2):507-514. PubMed ID: 33370585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study.
    Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
    J Affect Disord; 2018 Jan; 225():709-714. PubMed ID: 28922734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of low-dose ketamine infusion and repetitive transcranial magnetic stimulation in treatment-resistant depression: A posthoc pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Chen MH; Cheng CM; Li CT; Tsai SJ; Lin WC; Bai YM; Su TP
    Psychiatry Res; 2022 Oct; 316():114749. PubMed ID: 35940087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.
    Su TP; Chen MH; Li CT; Lin WC; Hong CJ; Gueorguieva R; Tu PC; Bai YM; Cheng CM; Krystal JH
    Neuropsychopharmacology; 2017 Dec; 42(13):2482-2492. PubMed ID: 28492279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion.
    Lin WC; Su TP; Li CT; Wu HJ; Tsai SJ; Bai YM; Tu PC; Chen MH
    J Psychopharmacol; 2023 Aug; 37(8):795-801. PubMed ID: 37332247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial.
    Beanes G; Caliman-Fontes AT; Souza-Marques B; Silva HDS; Leal GC; Carneiro BA; Guerreiro-Costa LNF; Figueiredo AV; Figueiredo CAV; Lacerda ALT; Costa RDS; Quarantini LC
    Clin Neuropharmacol; 2022 Nov-Dec 01; 45(6):151-156. PubMed ID: 36093918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression.
    Bottemanne H; Morlaas O; Claret A; Sharot T; Fossati P; Schmidt L
    JAMA Psychiatry; 2022 Nov; 79(11):1124-1132. PubMed ID: 36169969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.
    Chen MH; Lin WC; Li CT; Tsai SJ; Wu HJ; Bai YM; Hong CJ; Tu PC; Su TP
    Pharmacopsychiatry; 2022 Mar; 55(2):109-114. PubMed ID: 34530484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.
    Caliman-Fontes AT; Leal GC; Correia-Melo FS; Paixão CS; Carvalho MS; Jesus-Nunes AP; Vieira F; Magnavita G; Bandeira ID; Mello RP; Beanes G; Silva SS; Echegaray M; Carvalho LP; Machado P; Sampaio AS; Cardoso TA; Kapczinski F; Lacerda ALT; Quarantini LC
    Trends Psychiatry Psychother; 2023; 45():e20210298. PubMed ID: 34904800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response: Reexploring the Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression.
    Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
    J Clin Psychiatry; 2020 Nov; 81(6):. PubMed ID: 33176071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study.
    Chen MH; Lin WC; Tu PC; Li CT; Bai YM; Tsai SJ; Su TP
    J Affect Disord; 2019 Dec; 259():15-20. PubMed ID: 31437695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.